119 S5059 IS: To amend the Public Health Service Act to streamline the review of biosimilar biological products. U.S. Senate 2026-07-21 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II119th CONGRESS2d SessionS. 5059IN THE SENATE OF THE UNITED STATESJuly 21, 2026Mrs. Moody (for herself, Ms. Alsobrooks, Mr. Scott of Florida, and Ms. Blunt Rochester) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and PensionsA BILLTo amend the Public Health Service Act to streamline the review of biosimilar biological products.

1.

Streamlining biosimilar reviews

Section 351(k)(5) of the Public Health Service Act (42 U.S.C. 262(k)(5)) is amended—(1)by striking subparagraph (B); and(2)by redesignating subparagraph (C) as subparagraph (B).